Drug dispensing/prescription data
Data characterization of population-based data sources: ConcePTION pipeline
Finland
France
Italy
Norway
Spain
United Kingdom
EU PAS number:
EUPAS50142
First published:
22/02/2024
Study
Ongoing
Post-Authorisation Active Safety Surveillance Program Among Patients Treated With Tofacitinib for Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Juvenile Psoriatic Arthritis (PsA) Using Nationwide Swedish Healthcare Registers
Sweden
EU PAS number:
EUPAS107199
First published:
06/12/2024
Study
Planned
Cohort Study of Long-term Safety of Upadacitinib for the Treatment of Ulcerative Colitis and Crohn’s Disease in a Real-world Setting in Europe
Denmark
Spain
Sweden
EU PAS number:
EUPAS107124
First published:
08/08/2024
Study
Ongoing
A Non-Interventional Multi-Country Post-Authorisation Safety Study (PASS) to Assess the Incidence of Serious Infections & Malignancies in Systemic Lupus Erythematosus (SLE) Patients Exposed to Anifrolumab (SIMA PASS)
Denmark
France
Germany
Spain
EU PAS number:
EUPAS105690
First published:
02/07/2024
Study
Planned
Exposure to ACEi, ARB and statin drugs among women of child-bearing age in Denmark
Denmark
EU PAS number:
EUPAS106995
First published:
04/10/2023
Study
Ongoing
An Observational Study to Assess the Real-world Effectiveness and Safety of EVUSHELD™ (Tixagevimab/Cilgavimab) as Pre-exposure Prophylaxis Against COVID-19 Among EVUSHELD-eligible Populations in the United States Department of Defense Healthcare System (VALOR DOD)
United States
EU PAS number:
EUPAS106412
First published:
14/03/2024
Study
Ongoing
Characterization of neurodevelopmental disorders in children exposed in utero to valproate and/or other antiepileptic drugs with long-term follow-up: retrospective study of multiple European data sources (AVALON)
Denmark
Finland
France
Netherlands
Norway
Sweden
United Kingdom
EU PAS number:
EUPAS103711
First published:
22/01/2025
Study
Ongoing
Effectiveness and safety of MVA-BN vaccination against Mpox in at-risk individuals in the United States (USMVAc) (USMVAC study)
United States
EU PAS number:
EUPAS104386
First published:
23/04/2024
Study
Ongoing
Post-authorisation Safety Study of Tralokinumab Use in Pregnancy: An Observational Study Based on Electronic Healthcare Data
France
Germany
United States
EU PAS number:
EUPAS104085
First published:
20/09/2024
Study
Planned
Assesing the Safety of Antihypertensive medication in Pregnancy (ASAP)
Spain
EU PAS number:
EUPAS104849
First published:
23/04/2024
Study
Ongoing